Bulk medicaments containing alkaloids and their derivatives — not in dosage form or retail packaging — encompass a pharmacologically diverse group of APIs derived from plant or synthetic sources, including opioid alkaloids, xanthines, ergot alkaloids, and vinca alkaloids used in oncology and neurology. Many alkaloid-based APIs are controlled substances under the Controlled Substances Act, requiring DEA import permits in addition to FDA admissibility clearance, making dual-agency compliance a defining feature of this trade category. The NES designation excludes alkaloids classified elsewhere in the SITC schedule, so importers must confirm the specific compound is not captured by a more specific heading. These bulk materials typically move between API manufacturers and finished-drug producers under strict chain-of-custody documentation.

AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.